Pacheco Orozco, Rafael AdriánMontealegre Paez, Ana LorenaCayol, FedericoMartínez Gregorio, HéctorOliver, JavierFrecha, CeciliaVaca Paniagua, FelipePerdomo Lara, Sandra Janneth2020-09-022020-09-021549-490Xhttps://hdl.handle.net/20.500.12495/3934application/pdfengAttribution-NonCommercial-NoDerivatives 4.0 InternationalAR-V7 as a biomarker for resistance to treatment with abiraterone/enzalutamide in three Latin American countries: a hypothetical cost-saving analysisArtículo de revistaAndrogen receptor antagonistsBiomarkersCost savingsNeoplasm drug resistanceProstatic neoplasmsTherapeuticshttps://doi.org/10.1634/theoncologist.2020-0043instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquehttps://repositorio.unbosque.edu.coAR-V7 as a biomarker for resistance to treatment with abiraterone/enzalutamide in three Latin American countries: a hypothetical cost-saving analysisAcceso abiertohttps://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessAcceso abierto2020-07-28